ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesL57.3

L57.3

Billable

Poikiloderma of Civatte

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/06/2025

Code Description

ICD-10 L57.3 is a billable code used to indicate a diagnosis of poikiloderma of civatte.

Key Diagnostic Point:

Poikiloderma of Civatte is a skin condition characterized by a triad of symptoms: erythema, atrophy, and telangiectasia, primarily affecting the neck and upper chest. It is often associated with sun exposure, leading to a mottled appearance of the skin. The condition is more prevalent in women and typically presents in middle-aged individuals. The underlying anatomy involved includes the epidermis and dermis, where damage from ultraviolet (UV) radiation results in vascular changes and loss of collagen. Disease progression can lead to increased pigmentation and further skin atrophy if not managed. Diagnostic considerations include a thorough clinical examination and patient history, focusing on sun exposure and any associated symptoms. Biopsy may be performed to rule out other dermatological conditions, such as lupus erythematosus or other forms of dermatitis. Treatment options often involve sun protection measures, topical retinoids, and laser therapy to improve cosmetic appearance and manage symptoms.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Diagnostic complexity: Requires differentiation from other skin disorders
  • Treatment complexity: Involves multiple treatment modalities and patient compliance
  • Documentation requirements: Detailed patient history and clinical findings needed
  • Coding specificity: Requires accurate coding to avoid misclassification

Audit Risk Factors

  • Common coding errors: Misidentification of the condition or related skin disorders
  • Documentation gaps: Incomplete patient history or lack of clinical findings
  • Billing challenges: Potential for denials if documentation does not support the diagnosis

Specialty Focus

Medical Specialties

Dermatology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Primary care

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related ICD-10 Codes

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

Poikiloderma of Civatte has clinical significance as it can affect the quality of life due to cosmetic concerns. The condition is prevalent in populations with high sun exposure, highlighting the importance of sun protection measures. Understanding this condition can improve healthcare utilization patterns, as early intervention may prevent progression and associated complications. Epidemiologically, it underscores the need for public health initiatives focused on skin cancer prevention and awareness.

ICD-9 vs ICD-10

Poikiloderma of Civatte has clinical significance as it can affect the quality of life due to cosmetic concerns. The condition is prevalent in populations with high sun exposure, highlighting the importance of sun protection measures. Understanding this condition can improve healthcare utilization patterns, as early intervention may prevent progression and associated complications. Epidemiologically, it underscores the need for public health initiatives focused on skin cancer prevention and awareness.

Reimbursement & Billing Impact

Reimbursement considerations include the need for prior authorization for certain treatments, such as laser therapy. Common denials may arise from insufficient documentation or lack of evidence supporting the diagnosis. Best practices include ensuring that all treatment notes are detailed and that any procedures performed are clearly linked to the diagnosis of poikiloderma of Civatte.

Resources

Clinical References

  • •
    ICD-10 Official Guidelines for L00-L99
  • •
    Clinical Documentation Requirements

Coding & Billing References

  • •
    ICD-10 Official Guidelines for L00-L99
  • •
    Clinical Documentation Requirements

Frequently Asked Questions

What specific conditions are covered by L57.3?

L57.3 specifically covers poikiloderma of Civatte, which is characterized by skin changes due to sun exposure, including erythema, atrophy, and telangiectasia. It is important to differentiate it from other forms of poikiloderma and skin disorders.

When should L57.3 be used instead of related codes?

L57.3 should be used when the clinical presentation aligns with poikiloderma of Civatte, particularly when there is a history of sun exposure and the characteristic skin findings are present. It is essential to differentiate it from other poikilodermas or skin conditions that may present similarly.

What documentation supports L57.3?

Documentation for L57.3 should include a detailed patient history focusing on sun exposure, clinical findings such as the presence of erythema, atrophy, and telangiectasia, and any treatments attempted. Photographic evidence may also be beneficial.